PURA Rated BUY – Cannabis Stock Juggernaut Ready To Explode From $0.04 To $0.25
September 6, 2019 -- InvestorsHub NewsWire -- via www.nextbigticker.com -- Puration, Inc. (USOTC: PURA) is rated a BUY today by AmericanBulls (americanbulls.com/PURA). BullishInvestor (bullishinvestor.com/PURA) reports that PURA is signaling BULLISH. PURA is the maker of the number one sports fitness nutrition beverage with CBD, EVERx CBD Sports Water. The company has kept its head down this summer publishing little news but enough to let shareholders know the company has expanded its manufacturing capacity to meet growing demand. PURA also reported over $1 million in sales for the first six months of 2019 after reporting $1 million in sales for all of 2018. It’s been a slow summer for penny stocks in general, but now that Labor Day has past, cannabis stocks across the board are already picking up. PURA has been a historical juggernaut running last fall from $0.03 to a high of $0.25. The company has a history of publishing strong, regular news and is likely to pick up its PR program any minute now that summer has ended. With virtually no news, PURA has already been rated a BUY. With expanded beverage production capacity, dramatic sales growth and the magnitude of the EVERx Brand, it’s a good bet to get in now at $0.04 and prepare to ride the next run driven by this juggernaut’s ongoing momentum.
AmericanBulls on PURA:
“Let’s jump on our white horses and go for a bullish ride. The bullish pattern that was previously identified is finally confirmed and a BUY signal is generated. Most probably, it is the right time to participate in bullish fervor. The market is telling you about a new profit. Do not miss this bullish opportunity.”
BullishInvestor on PURA:
“The most recent Candle Stick pattern for PURA is the Doji. Overall the technical indicators are signaling a bullish reading for PURA. As such, it may be a wise decision to consider PURA at these price levels … This stock now finds itself with a new BULLISH rating and is worthy of a new look from a technical analysis perspective.”
PURA’s EVERx CBD Sports Water utilizes Kali-Extracts’ (USOTC: KALY) U.S. Patented Cannabis Extraction Process. PURA holds the only license of the Patent for use in a beverage. KALY has recently made news with the filing of a new Patent for a cannabis extract to treat COPD. PURA may have benefited from recent KALY news.
PURA’s EVERx CBD Sports Water is available for sale online through the website www.USMJ.com from North American Cannabis Holdings, Inc. (USOTC: USMJ).
NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.